The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model
International Journal of Molecular Sciences · 09.08.2024 · 25 (16) · 8706
DOI: 10.3390/ijms25168706 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.08.2024. Verfasst von Yan Zhang Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Industry Ph.D. Program, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Letrozole, Disease Models, Animal, Gastrointestinal Microbiome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bened Biomedical Co., Ltd..
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age globally. Emerging evidence suggests that the dysregulation of microRNAs (miRNAs) and gut dysbiosis are linked to the development of PCOS. In this study, the effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 (DSM 27449) were investigated in a rat model of PCOS induced by letrozole. The administration of DSM 27449 resulted in improved ovarian function, reduced cystic follicles, and lower serum testosterone levels. Alterations in miRNA expressions and increased levels of the pro-apoptotic protein Bax in ovarian tissues were observed in PCOS-like rats. Notably, the administration of DSM 27449 restored the expression of miRNAs, including miR-30a-5p, miR-93-5p, and miR-223-3p, leading to enhanced ovarian function through the downregulation of Bax expressions in ovarian tissues. Additionally, 16S rRNA sequencing showed changes in the gut microbiome composition after letrozole induction. The strong correlation between specific bacterial genera and PCOS-related parameters suggested that the modulation of the gut microbiome by DSM 27449 was associated with the improvement of PCOS symptoms. These findings demonstrate the beneficial effects of DSM 27449 in ameliorating PCOS symptoms in letrozole-induced PCOS-like rats, suggesting that DSM 27449 may serve as a beneficial dietary supplement with the therapeutic potential for alleviating PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Industry Ph.D. Program, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
- Bened Biomedical Co., Ltd., Taipei 115011, Taiwan.
- Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
ORCID-Profile: Shih-Hsuan Cheng, Chien-Chen Wu, Ying-Chieh Tsai
Förderung
- Bened Biomedical Co., Ltd.
Zitieren
APA
Lee, Y. Z., Cheng, S. H., Lin, Y. F., Wu, C. C., & Tsai, Y. C. (2024). The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model. International Journal of Molecular Sciences, 25(16), 8706. https://doi.org/10.3390/ijms25168706
Vancouver
Lee YZ, Cheng SH, Lin YF, Wu CC, Tsai YC. The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model. International Journal of Molecular Sciences. 2024;25(16):8706. doi:10.3390/ijms25168706
BibTeX
@article{Lee2024,
author = {Lee, Yan Zhang and Cheng, Shih-Hsuan and Lin, Yu-Fen and Wu, Chien-Chen and Tsai, Ying-Chieh},
title = {The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {8706},
doi = {10.3390/ijms25168706}
}
EUVIMED